Alumis, Inc. (ALMS)
9.20
+0.02
(+0.22%)
USD |
NASDAQ |
Sep 14, 16:00
9.20
0.00 (0.00%)
After-Hours: 18:07
Alumis Price to Book Value : 2.615 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.609 |
| September 10, 2026 | 2.814 |
| September 09, 2026 | 2.785 |
| September 08, 2026 | 3.007 |
| September 04, 2026 | 3.155 |
| September 03, 2026 | 3.229 |
| September 02, 2026 | 2.942 |
| September 01, 2026 | 2.691 |
| August 31, 2026 | 6.198 |
| August 28, 2026 | 6.360 |
| August 27, 2026 | 6.596 |
| August 26, 2026 | 6.713 |
| August 25, 2026 | 6.810 |
| August 24, 2026 | 6.545 |
| August 21, 2026 | 6.869 |
| August 20, 2026 | 6.497 |
| August 19, 2026 | 6.818 |
| August 18, 2026 | 7.071 |
| August 17, 2026 | 7.247 |
| August 14, 2026 | 7.193 |
| August 13, 2026 | 6.937 |
| August 12, 2026 | 7.261 |
| August 11, 2026 | 7.210 |
| August 10, 2026 | 7.824 |
| August 07, 2026 | 7.844 |
| Date | Value |
|---|---|
| August 06, 2026 | 7.901 |
| August 05, 2026 | 7.708 |
| August 04, 2026 | 7.708 |
| August 03, 2026 | 7.423 |
| July 31, 2026 | 8.029 |
| July 30, 2026 | 8.228 |
| July 29, 2026 | 7.497 |
| July 28, 2026 | 7.682 |
| July 27, 2026 | 7.696 |
| July 24, 2026 | 7.958 |
| July 23, 2026 | 8.043 |
| July 22, 2026 | 8.188 |
| July 21, 2026 | 8.540 |
| July 20, 2026 | 7.952 |
| July 17, 2026 | 8.145 |
| July 16, 2026 | 7.739 |
| July 15, 2026 | 8.188 |
| July 14, 2026 | 7.753 |
| July 13, 2026 | 7.986 |
| July 10, 2026 | 8.046 |
| July 09, 2026 | 8.611 |
| July 08, 2026 | 8.452 |
| July 07, 2026 | 8.319 |
| July 06, 2026 | 7.750 |
| July 02, 2026 | 7.531 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.548 |
| Corcept Therapeutics, Inc. | 17.08 |
| Aclaris Therapeutics, Inc. | 6.341 |
| Crinetics Pharmaceuticals, Inc. (DELISTED) | 7.541 |
| ANI Pharmaceuticals, Inc. | 2.706 |
Price to Book Value Related Metrics
| PS Ratio | 143.50 |
| Price | 9.20 |
| Earnings Yield | -41.40% |
| Market Cap | 1.182B |